[糖尿病患者高胆固醇血症纠正的新可能性]
[New possibilities of correction of hypercholesterolemia in patients with diabetes mellitus].
作者信息
Pan'kiv V I
出版信息
Lik Sprava. 2014 May-Jun(5-6):56-67.
PMID:25906648
Abstract
This article presents scientific data to prove effect of statins on carbohydrate metabolism and the need to optimize hypolipidemic therapy in patients with diabetes. Systematized the available scientific data on the mechanism of action, parameters of hypolipidemic activity and the possibility of using policosanol. Author is giving us his own clinical experience with herbal drug FitoStatin (policosanol) in patients with diabetes based on 6-month follow-up.
摘要
本文提供了科学数据，以证明他汀类药物对碳水化合物代谢的影响以及优化糖尿病患者降脂治疗的必要性。对有关聚多卡醇作用机制、降脂活性参数及使用可能性的现有科学数据进行了系统化整理。作者基于6个月的随访，向我们介绍了他使用草药药物FitoStatin（聚多卡醇）治疗糖尿病患者的临床经验。
相似文献
1
[New possibilities of correction of hypercholesterolemia in patients with diabetes mellitus].[糖尿病患者高胆固醇血症纠正的新可能性]
Lik Sprava. 2014 May-Jun(5-6):56-67.
2
3
[HMG-CoA reductase inhibitors].[羟甲基戊二酰辅酶A还原酶抑制剂]
Nihon Rinsho. 2001 Mar;59 Suppl 3:578-86.
4
[Lipid therapy in patients with diabetes].[糖尿病患者的脂质治疗]
Wien Med Wochenschr. 2010 Jan;160(1-2):25-9. doi: 10.1007/s10354-010-0745-x.
5
6
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.在管理式医疗环境中，以低高密度脂蛋白胆固醇为靶点降低残余心血管风险。
J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1.
7
Importance of high-density lipoprotein cholesterol control during pravastatin treatment in hypercholesterolemic Japanese with type 2 diabetes mellitus: a post hoc analysis of MEGA study.美格列醇治疗 2 型糖尿病伴高胆固醇血症患者的高密度脂蛋白胆固醇控制的重要性：MEGA 研究的事后分析。
Diabetes Res Clin Pract. 2013 May;100(2):e31-3. doi: 10.1016/j.diabres.2013.02.003. Epub 2013 Mar 19.
8
[Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia].[聚多卡醇与两种HMG-CoA还原酶抑制剂对II型高胆固醇血症的比较疗效]
Rev Med Chil. 1999 Mar;127(3):286-94.
9
Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.依折麦布与普伐他汀或辛伐他汀联合使用十二个月的耐受性及对血脂的影响：两项高胆固醇血症患者开放标签扩展研究的结果
Clin Ther. 2008 Dec;30(12):2280-97. doi: 10.1016/j.clinthera.2008.12.008.
10
Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors.HMG-CoA还原酶抑制剂治疗期间血清辅酶Q10的剂量相关性降低。
Mol Aspects Med. 1997;18 Suppl:S137-44. doi: 10.1016/s0098-2997(97)00014-9.
Zotero 插件